Citation Impact
Citing Papers
Long-Term Prognosis of Patients With Kawasaki Disease Complicated by Giant Coronary Aneurysms
2011
Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia.
2006
Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2008) : Digest Version
2010
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
2009 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation
2011 StandoutNobel
Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms
2010
Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin Resistance
2010
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2008 Standout
The Biophysical Properties of the Aorta Are Altered Following Kawasaki Disease
2013
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
2010 Standout
Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey
2012
The right ventricle in congenital heart disease
2006
Color Doppler Tissue Imaging for Evaluation of Right Ventricular Systolic Function in Patients with Congenital Heart Disease
2005
Pseudonormalized doppler totalejection isovolume (Tei) index in patients with right ventricularacute myocardial infarction
2003
Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease
2007
Analysis of Potential Risk Factors Associated With Nonresponse to Initial Intravenous Immunoglobulin Treatment Among Kawasaki Disease Patients in Japan
2008
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
2006
3D Echocardiography: A Review of the Current Status and Future Directions
2007
Direct Measurement of Vena Contracta Area by Real-Time 3-Dimensional Echocardiography for Assessing Severity of Mitral Regurgitation
2009
Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging for Assessing Right Ventricular Function in Adults With Repaired Tetralogy of Fallot
2007
When Children With Kawasaki Disease Grow Up
2009
Right Ventricular Tei Index in Children: Effect of Method, Age, Body Surface Area, and Heart Rate
2007
Myocardial Performance Index in Evaluation of Acute Right Ventricular Myocardial Infarction
2004
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
2020 Standout
Do Kawasaki disease patients without coronary artery abnormalities need a long‐term follow‐up? A myocardial single‐photon emission computed tomography pilot study
2009
Regional myocardial velocities and isovolumic contraction acceleration before and after device closure of atrial septal defects: A color tissue Doppler study
2005
Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease
2010
Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki Disease
2009
Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1α and HIF-2α
2010 StandoutNobel
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Epidemiologic Features of Kawasaki Disease in Japan: Results from the Nationwide Survey in 2005-2006
2008
The human side of hypoxia‐inducible factor
2008 StandoutNobel
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Oxygen homeostasis
2009 StandoutNobel
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Delayed Diagnosis of Kawasaki Disease: What Are the Risk Factors?
2007
An approach to the diagnosis and management of systemic vasculitis
2010
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Assessment of Systemic Right Ventricular Function in Patients With Transposition of the Great Arteries Using the Myocardial Performance Index
2004
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease
2010
Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease
2006
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Long-Term Outcome of Kawasaki Disease
2008
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2008) - Digest Version -
2010
Mortality Among Persons With a History of Kawasaki Disease in Japan Mortality Among Males With Cardiac Sequelae is Significantly Higher Than That of the General Population
2007
Quantifying Pulmonary Regurgitation and Right Ventricular Function in Surgically Repaired Tetralogy of Fallot
2012
Electrical Resynchronization
2003
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of Jun Furui being referenced
Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy
2000
Quantitation of the Global Right Ventricular Function in Children with Normal Heart and Congenital Heart Disease: A Right Ventricular Myocardial Performance Index
2000
Assessment of the Ability of Myocardial Contrast Echocardiography with Harmonic Power Doppler Imaging to Identify Perfusion Abnormalities in Patients with Kawasaki Disease at Rest and During Dipyridamole Stress
2002
Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease
2005
Early intravenous gamma-globulin treatment for kawasaki disease: The nationwide surveys in Japan
2004
Increased Angiogenic Growth Factor in Cyanotic Congenital Heart Disease
2003
Sequential Follow-Up Results of Catheter Intervention for Coronary Artery Lesions After Kawasaki Disease
2002
Quantitative Assessment of Severity of Ventricular Septal Defect by Three-Dimensional Reconstruction of Color Doppler–Imaged Vena Contracta and Flow Convergence Region
2001
Older Age Is a Risk Factor for the Development of Cardiovascular Sequelae in Kawasaki Disease
2004
Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions
2002